Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Should I get the shingles vaccine?

Kimm KL.

JAAPA. 2012 Sep;25(9):65. No abstract available.

PMID:
22991889
2.

Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.

Betts RF.

J Am Acad Dermatol. 2007 Dec;57(6 Suppl):S143-7.

PMID:
18021866
3.

Zoster vaccine protects against shingles.

[No authors listed]

BMJ. 2013 Apr 17;346:f2389. doi: 10.1136/bmj.f2389. No abstract available.

PMID:
23596220
4.

Health economic evaluation of a vaccine for the prevention of herpes zoster (shingles) and post-herpetic neuralgia in adults in Belgium.

Annemans L, Bresse X, Gobbo C, Papageorgiou M.

J Med Econ. 2010;13(3):537-51. doi: 10.3111/13696998.2010.502854.

PMID:
20707768
5.

Herpes zoster vaccine (Zostavax) revisited.

[No authors listed]

Med Lett Drugs Ther. 2010 May 31;52(1339):41. No abstract available.

PMID:
20508580
6.

Zoster vaccine live for the prevention of shingles in the elderly patient.

Zussman J, Young L.

Clin Interv Aging. 2008;3(2):241-50. Review.

7.

Patient information. Should I get the shingles vaccine?

[No authors listed]

JAAPA. 2007 Jul;20(7):56. No abstract available.

PMID:
17695100
8.

Prevention and management of trigeminal herpes zoster and postherpetic neuralgia.

Closmann JJ, Fielding CG, Pogrel MA.

Gen Dent. 2008 Sep-Oct;56(6):563-6; quiz 567-8, 591-2.

PMID:
18810918
9.

Shingles vaccine: who should get it?

Johnson AM.

S D Med. 2006 Aug;59(8):349-50. No abstract available.

PMID:
16941852
10.

[Herpes zoster and postherpetic neuralgia: advantages of the vaccination].

Cañada JL.

Rev Esp Quimioter. 2009 Nov;22 Suppl 1:19-21. Review. Spanish. No abstract available.

11.

Vaccine against herpes zoster halves incidence in older people, finds study.

Ramsey S.

BMJ. 2013 Apr 12;346:f2349. doi: 10.1136/bmj.f2349. No abstract available.

PMID:
23585074
12.

Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Rothberg MB, Virapongse A, Smith KJ.

Clin Infect Dis. 2007 May 15;44(10):1280-8.

PMID:
17443464
13.

The looming rash of herpes zoster and the challenge of adult immunization.

Donahue JG, Belongia EA.

Ann Intern Med. 2010 May 4;152(9):609-11. doi: 10.7326/0003-4819-152-9-201005040-00011. No abstract available.

PMID:
20439578
14.

The shingles vaccine. Why hasn't it caught on? The cost and other factors are to blame.

[No authors listed]

Harv Health Lett. 2007 Aug;32(10):1-2. No abstract available.

PMID:
17717891
15.

Why should older adults receive the shingles vaccine?

Harkness TL.

J Gerontol Nurs. 2010 Oct;36(10):51-5. doi: 10.3928/00989134-20100504-06.

PMID:
20506935
16.

Vaccination to prevent herpes zoster in older adults.

Gnann JW Jr.

J Pain. 2008 Jan;9(1 Suppl 1):S31-6. doi: 10.1016/j.jpain.2007.10.007. Review.

PMID:
18166463
17.

Cost-effectiveness of herpes zoster vaccine: flawed assumptions regarding efficacy against postherpetic neuralgia.

Brisson M, Pellissier JM, Levin MJ.

Clin Infect Dis. 2007 Dec 1;45(11):1527-9. No abstract available.

PMID:
17990240
18.

Summaries for patients. Safety of the vaccine to prevent shingles.

[No authors listed]

Ann Intern Med. 2010 May 4;152(9):I20. doi: 10.7326/0003-4819-152-9-201005040-00001. No abstract available.

PMID:
20439568
19.
20.

Shingles (Herpes Zoster) Vaccine (Zostavax(®)): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia.

Keating GM.

BioDrugs. 2016 Jun;30(3):243-54. doi: 10.1007/s40259-016-0180-7. Review.

PMID:
27189459
Items per page

Supplemental Content

Support Center